Poster Hall Hours

Tuesday, May 10, 2016
3:00 pm - 6:30 pm

Wednesday, May 11, 2016
10:00 am - 6:30 pm

Thursday, May 12, 2016
10:30 am - 2:00 pm

For more information on how Informa manages and shares your personal data please see our Privacy Policy

WATCH NOW

Country/Region *

First Name *

Surname *

Business Email *

Company Name *

Job Title *

Zip / Postal Code *

Business Cell Phone Number

How familiar are you with Cencora and our services? *

I have never heard of Cencora

I have heard of Cencora but haven’t used your services

I have used your services before

I am a current customer

Please tick this box if you do not wish to receive news and promotions from Informa Connect about products and services relevant to me including information from our carefully selected partners. We will not share your details unless you agree to us doing so directly.

Please tick this box if you do not wish to hear from Cencora sponsors about their products and services relevant to you.

By submitting this form, you understand that Cencora may process your data as described in the Cencora privacy statement.

Now Available On-Demand

In the ever-evolving pharmaceutical landscape, our panel will delve into the strategic complexities crucial for manufacturers aiming to expand successfully into European markets.

Launching biopharmaceutical products globally presents a host of challenges, especially for emerging companies with limited resources and experience. The intricate web of regulations, market dynamics, regulatory hurdles, and strategic planning required for a successful launch can be daunting.

This panel discussion will navigate these challenges, and the nuances involved in European biopharma launches. We will hear from industry experts who will share valuable insights to guide your organization through similar initiatives.

Through real-world experiences and expert perspectives, we will uncover the key decisions, innovative strategies, and collaborative efforts necessary to navigate diverse regulatory environments, optimize pricing strategies, and achieve effective market entry in resource-constrained settings.

Join us to hear industry leaders share their journeys of success and the challenges they faced in launching products globally.

Our goal is for you to discover actionable strategies, best practices, and valuable lessons learned that can empower your organization in the ever-evolving global pharmaceutical marketplace.

Jacob Liawatidewi, Executive Vice President, Corporate Administration Center, Amphastar Pharmaceuticals

Speakers:

Bio: Jacob Liawatidewi, BSc in Biology, MBA, Executive JD, is currently Executive Vice President of Corporate Administration Center, member of the Board of the Directors, and Corporate Secretary at Amphastar Pharmaceuticals.

Since joining the company in 1997, Mr. Liawatidewi has held various roles in Amphastar’s business development, sales, and marketing.

He was appointed as Company Secretary, effective June 2013. Since 2020, Mr. Liawatidewi has served as Executive Vice President, Corporate Administration Center. Mr. Liawatidewi is President of Amphastar France Pharmaceuticals.

Jan Van Acker, Strategic Advisor in Healthcare and Biopharmaceuticals, Self-employed

Bio: Jan Van Acker is a senior global biopharma and healthcare executive based in Switzerland. With a background in business and engineering, and a Master's degrees from MIT and MIT’s Sloan School of Management, Jan has held key leadership roles at MSD and Merck. He has a proven track record of driving innovation and growth in healthcare, serving previously as a Board Member at Merck’s Global Health Innovation Fund LLC and currently a.o. as a strategic advisor to the innovation hub of one of the world’s leading hospitals. Jan is passionate about making a difference in the world and excels in coaching and guiding leaders to achieve success at scale.

Cracking the code: Mastering biopharma launches in Europe

Kevin McDermott, Vice President, International Commercialization, Cencora

Bio: Kevin McDermott, Vice President International Commercialization, recently joined Cencora to help organizations with their portfolio and globalization strategies. Prior to joining the Cencora team, Kevin was the Chief Commercialization lead for multiple pre-commercial and commercial biopharma organizations.

In his role he is responsible for leading overall initiatives that drive product launch excellence, comprehensive commercialization planning and driving strategic market synergies that are aligned to life cycle management.

He brings over 36 years of diverse experience across the life sciences industry and has served as the Chief Commercial Officer for various manufacturer partners. His background is rich in the market access arena and spans both globally and US based. He has served in leadership roles for Eversana, Summit Therapeutics, Insmed, Aptalis Pharma, Daiichi Sankyo, Sanofi Pasteur and Warner Lambert.

Mr. McDermott dual majored and received his Bachelor’s in Science degree in Pre-med and Bachelor of Arts in English from Hillsdale College.

Sandra Anderson, Senior Vice President, International Commercialization, Cencora

Bio: Sandra Anderson is Sr. Vice President of International Commercialization at Cencora and brings over 20 years of pharmaceutical experience on both the manufacturer and consulting side. Focused on enterprise strategy, innovation, and commercialization for specialty manufacturers, Sandra has overseen numerous initiatives within the commercialization space including new business development, digital innovation, stakeholder relations, pharmacovigilance, quality, regulatory affairs, market access, and health policy advocacy. Through this work in her career, Sandra has supported a number of specialty launches in Canada and globally. As a result, she deeply understands the commercialization journey for emerging biotechs as they navigate the international market, having supported many of them on their entry into different regions globally. In her current role as SVP International Commercialization, Sandra leads the International Commercialization team focused on guiding small to medium business manufacturer partners through their commercialization journey and to proactively ensure we are providing them with the right solutions to support their global launches in an integrated way.

Sandra is an international speaker who focuses on the complexity of bringing a product to market in the various global regulatory environments and how to bridge the gaps for optimal success. She is an expert in the rare disease space and chaired the Canadian Orphan Rare Disease Patient group for a number of years. Holding a Bachelor of Arts from McMaster University and an MBA focusing on International Marketing, Sandra is also a Certified Clinical Research Associate (CCRA).